Cargando…
Prediction of Anticancer Peptides with High Efficacy and Low Toxicity by Hybrid Model Based on 3D Structure of Peptides
Recently, anticancer peptides (ACPs) have emerged as unique and promising therapeutic agents for cancer treatment compared with antibody and small molecule drugs. In addition to experimental methods of ACPs discovery, it is also necessary to develop accurate machine learning models for ACP predictio...
Autores principales: | Zhao, Yuhong, Wang, Shijing, Fei, Wenyi, Feng, Yuqi, Shen, Le, Yang, Xinyu, Wang, Min, Wu, Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198792/ https://www.ncbi.nlm.nih.gov/pubmed/34073203 http://dx.doi.org/10.3390/ijms22115630 |
Ejemplares similares
-
Identifying anticancer peptides by using improved hybrid compositions
por: Li, Feng-Min, et al.
Publicado: (2016) -
The anticancer efficacy of paclitaxel liposomes modified with low-toxicity hydrophobic cell-penetrating peptides in breast cancer: an in vitro and in vivo evaluation
por: Zhang, Qi, et al.
Publicado: (2018) -
A Novel Hybrid Sequence-Based Model for Identifying Anticancer Peptides
por: Xu, Lei, et al.
Publicado: (2018) -
Bioactive peptides for anticancer therapies
por: Zhang, Yehao, et al.
Publicado: (2023) -
Peptides with Dual Antimicrobial–Anticancer Activity: Strategies to Overcome Peptide Limitations and Rational Design of Anticancer Peptides
por: Liscano, Yamil, et al.
Publicado: (2020)